Polymeric micelles for drug delivery

Polymeric micelles have been the subject of many studies in the field of drug delivery for the past two decades. The interest has specifically been focused on the potential application of polymeric micelles in three major areas in drug delivery: drug solubilisation, controlled drug release and drug targeting. In this context, polymeric micelles consisting of poly(ethylene oxide)-b-poly(propylene oxide), poly(ethylene oxide)-b-poly(ester)s and poly(ethylene oxide)-b-poly(amino acid)s have shown a great promise and are in the front line of development for various applications. The purpose of this manuscript is to provide an update on the current status of polymeric micelles for each application and highlight important parameters that may lead to the development of successful polymeric micellar systems for individual delivery requirements.

[1]  Mark L. Greenberg,et al.  Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  V. Torchilin,et al.  Structure and design of polymeric surfactant-based drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[3]  M. Yessine,et al.  Preparation, characterization, cytotoxicity and biodistribution of docetaxel-loaded polymeric micelle formulations , 2005 .

[4]  V. Alakhov,et al.  Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. , 1996, Cancer research.

[5]  J. H. Lee,et al.  Clonazepam release from core-shell type nanoparticles of poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) triblock copolymers. , 2000, International journal of pharmaceutics.

[6]  G. Kwon,et al.  Micelle-like structures of poly(ethylene oxide)-block-poly(2-hydroxyethyl aspartamide)-methotrexate conjugates , 1999 .

[7]  K. Kataoka,et al.  Block copolymer micelles for drug delivery: design, characterization and biological significance. , 2001, Advanced drug delivery reviews.

[8]  T. Okano,et al.  Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[9]  A. Kabanov,et al.  An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Lawrence Mayer,et al.  Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel , 1997, Anti-cancer drugs.

[11]  D. Christensen,et al.  Ultrasound-triggered drug targeting of tumors in vitro and in vivo. , 2004, Ultrasonics.

[12]  K. Kataoka,et al.  Lactose-installed poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles exhibit fast-rate binding and high affinity toward a protein bed simulating a cell surface. A surface plasmon resonance study. , 2003, Bioconjugate chemistry.

[13]  Marie-Hélène Dufresne,et al.  Thiol-functionalized polymeric micelles: from molecular recognition to improved mucoadhesion. , 2005, Bioconjugate chemistry.

[14]  W. Bennett,et al.  Chronic cyclosporine nephrotoxicity , 1998, Current opinion in nephrology and hypertension.

[15]  K. Ulbrich,et al.  Polymeric micellar pH-sensitive drug delivery system for doxorubicin. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[16]  N. Nishiyama,et al.  Polyion complex micelles of pDNA with acetal-poly(ethylene glycol)-poly(2-(dimethylamino)ethyl methacrylate) block copolymer as the gene carrier system: physicochemical properties of micelles relevant to gene transfection efficacy. , 2004, Biomacromolecules.

[17]  M. Cristea,et al.  Engineering Polysaccharide-Based Polymeric Micelles to Enhance Permeability of Cyclosporin A Across Caco-2 Cells , 2005, Pharmaceutical Research.

[18]  Jaeyoung Lee,et al.  Incorporation and release behavior of hydrophobic drug in functionalized poly(D,L-lactide)-block-poly(ethylene oxide) micelles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[19]  A. Fahr,et al.  Liposomal Formulations of Cyclosporin A: Influence of Lipid Type and Dose on Pharmacokinetics , 1995, Pharmaceutical Research.

[20]  John Samuel,et al.  Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. , 2002, Advanced drug delivery reviews.

[21]  T. Okano,et al.  Biodistribution of Micelle-Forming Polymer–Drug Conjugates , 1993, Pharmaceutical Research.

[22]  H. Ringsdorf,et al.  Polymeric Antitumor Agents on a Molecular and on a Cellular Level , 1981 .

[23]  I. Rubinstein,et al.  A Novel Formulation of VIP in Sterically Stabilized Micelles Amplifies Vasodilation In Vivo , 2004, Pharmaceutical Research.

[24]  Yokoyama Masayuki,et al.  Polymer micelles as novel drug carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer , 1990 .

[25]  T. Okano,et al.  Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. , 1991, Cancer research.

[26]  Kazunori Kataoka,et al.  Lactose-installed poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles exhibit fast-rate binding and high affinity toward a protein bed simulating a cell surface. A surface plasmon resonance study. , 2003 .

[27]  H. Burt,et al.  Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers. , 1997, Journal of pharmaceutical sciences.

[28]  Tae-You Kim,et al.  Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies , 2004, Clinical Cancer Research.

[29]  D. Brocks,et al.  Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution. , 2005, Biomaterials.

[30]  N. Nishiyama,et al.  Cisplatin‐incorporated Polymeric Micelles Eliminate Nephrotoxicity, While Maintaining Antitumor Activity , 2001, Japanese journal of cancer research : Gann.

[31]  T. Okano,et al.  Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide). , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[32]  A. Tibell,et al.  Dissolving intravenous cyclosporin A in a fat emulsion carrier prevents acute renal side effects in the rat , 1993, Transplant international : official journal of the European Society for Organ Transplantation.

[33]  T. Okano,et al.  Reduction of the Side Effects of an Antitumor Agent, KRN5500, by Incorporation of the Drug into Polymeric Micelles , 1999, Japanese journal of cancer research : Gann.

[34]  Kazunori Kataoka,et al.  Block copolymer micelles for delivery of gene and related compounds. , 2002, Advanced drug delivery reviews.

[35]  G. Kwon,et al.  Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity. , 2003, Biomacromolecules.

[36]  K. Kataoka,et al.  Preparation of adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. A new type of polymeric anticancer agent , 1987 .

[37]  H. Fain,et al.  Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers. , 2004, Molecular pharmaceutics.

[38]  Teruo Okano,et al.  Preparation and Characterization of the Micelle-Forming Polymeric Drug Indomethacin-lncorporated Polyfethylene oxide)-Poly(β-benzyl L-aspartate) Block Copolymer Micelles , 1996 .

[39]  J. Leroux,et al.  Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[40]  T. Okano,et al.  Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. , 1999, Journal of drug targeting.

[41]  Alexander V Kabanov,et al.  Optimal Structure Requirements for Pluronic Block Copolymers in Modifying P-glycoprotein Drug Efflux Transporter Activity in Bovine Brain Microvessel Endothelial Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.

[42]  G. Kwon,et al.  Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[43]  E. Roux,et al.  N-isopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[44]  T. Okano,et al.  Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[45]  V. Lenaerts,et al.  In‐vitro and in‐vivo evaluation of pH‐responsive polymeric micelles in a photodynamic cancer therapy model , 2001, The Journal of pharmacy and pharmacology.

[46]  S Sardari,et al.  In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta benzyl L aspartate) micelles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[47]  T. Okano,et al.  In vivo antitumor activity of polymeric micelle anticancer drug against murine C 26 tumor , 1994 .

[48]  A. Kabanov,et al.  Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells. , 1999, Bioconjugate chemistry.

[49]  G. Kwon,et al.  Block Copolymer Micelles for the Encapsulation and Delivery of Amphotericin B , 2002, Pharmaceutical Research.

[50]  V. Lenaerts,et al.  Optimizing pH-responsive Polymeric Micelles for Drug Delivery in a Cancer Photodynamic Therapy Model , 2002, Journal of drug targeting.

[51]  J. Leroux,et al.  Novel Polymeric Micelles Based on the Amphiphilic Diblock Copolymer Poly(N-vinyl-2-pyrrolidone)-block-poly(D,L-lactide) , 2001, Pharmaceutical Research.

[52]  A. Kabanov,et al.  Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. , 1996, Bioconjugate chemistry.

[53]  Alexander V. Kabanov,et al.  Effects of Pluronic P85 Unimers and Micelles on Drug Permeability in Polarized BBMEC and Caco-2 Cells , 1998, Pharmaceutical Research.

[54]  T. Okano,et al.  Control of adriamycin cytotoxic activity using thermally responsive polymeric micelles composed of poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(d,l-lactide) , 1999 .

[55]  N. Nishiyama,et al.  Differential gene expression profile between PC-14 cells treated with free cisplatin and cisplatin-incorporated polymeric micelles. , 2003, Bioconjugate chemistry.

[56]  T. Okano,et al.  Incorporation of the Anticancer Agent KRN5500 into Polymeric Micelles Diminishes the Pulmonary Toxicity , 2002, Japanese journal of cancer research : Gann.

[57]  Kozo Nakamura,et al.  Polyion complex micelles from plasmid DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer as serum-tolerable polyplex system: physicochemical properties of micelles relevant to gene transfection efficiency. , 2003, Biomaterials.

[58]  R. Duncan.  The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.

[59]  Naoki Kanayama,et al.  Lactose-conjugated polyion complex micelles incorporating plasmid DNA as a targetable gene vector system: their preparation and gene transfecting efficiency against cultured HepG2 cells. , 2004, Journal of Controlled Release.

[60]  J. Leroux,et al.  Preparation and characterization of water-soluble pH-sensitive nanocarriers for drug delivery. , 2004, International journal of pharmaceutics.

[61]  Vladimir P Torchilin,et al.  PEG-based micelles as carriers of contrast agents for different imaging modalities. , 2002, Advanced drug delivery reviews.

[62]  G. Kwon,et al.  Influencing factors on in vitro micelle stability of adriamycin-block copolymer conjugates , 1994 .

[63]  M. Francis,et al.  Solubilization of poorly water soluble drugs in micelles of hydrophobically modified hydroxypropylcellulose copolymers. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[64]  J. Nah,et al.  Adriamycin release from flower-type polymeric micelle based on star-block copolymer composed of poly(gamma-benzyl L-glutamate) as the hydrophobic part and poly(ethylene oxide) as the hydrophilic part. , 1999, International journal of pharmaceutics.

[65]  A. G. Ellis,et al.  Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80 , 1996, Cancer Chemotherapy and Pharmacology.

[66]  J. Nah,et al.  Clonazepam release from core-shell type nanoparticles of poly(ε-caprolactone)/poly(ethylene glycol)/poly(ε-caprolactone) triblock copolymers , 2000 .

[67]  H. S. Oh,et al.  In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[68]  J. Herron,et al.  Micellar delivery of doxorubicin and its paramagnetic analog, ruboxyl, to HL-60 cells: effect of micelle structure and ultrasound on the intracellular drug uptake. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[69]  I. Rubinstein,et al.  All d-VIP mitigates vasodilation elicited by l-VIP, micellar l-VIP and micellar PACAP1–38, but not PACAP1–38, in vivo , 2005, Peptides.

[70]  Y. Sugiyama,et al.  Cisplatin-Loaded Polymer-Metal Complex Micelle with Time-Modulated Decaying Property as a Novel Drug Delivery System , 2001, Pharmaceutical Research.

[71]  Vladimir P Torchilin,et al.  Preparation and in vitro synergistic anticancer effect of vitamin K3 and 1,8-diazabicyclo[5,4,0]undec-7-ene in poly(ethylene glycol)-diacyllipid micelles. , 2004, International journal of pharmaceutics.

[72]  G. Kwon,et al.  The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide). , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[73]  N. Melik-Nubarov,et al.  The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles , 1989, FEBS letters.

[74]  T. Okano,et al.  Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[75]  John K. Jackson,et al.  Development of amphiphilic diblock copolymers as micellar carriers of taxol , 1996 .

[76]  T. Okano,et al.  Preparation and Characterization of Self-Assembled Polymer−Metal Complex Micelle from cis-Dichlorodiammineplatinum(II) and Poly(ethylene glycol)−Poly(α,β-aspartic acid) Block Copolymer in an Aqueous Medium , 1999 .

[77]  W. Hunter,et al.  Development of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel , 1999 .

[78]  D. Maysinger,et al.  Copolymer drug carriers : conjugates, micelles and microspheres , 1999 .

[79]  Hesson Chung,et al.  Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[80]  T. Park,et al.  Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[81]  N. Nishiyama,et al.  Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum(II) in the core. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[82]  G. Kwon,et al.  Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[83]  N. Rapoport.  Combined cancer therapy by micellar-encapsulated drug and ultrasound. , 2004, International journal of pharmaceutics.

[84]  Yokoyama Masayuki,et al.  Block copolymer micelles as vehicles for drug delivery , 1993 .

[85]  Teruo Okano,et al.  Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-Adriamycin conjugates , 1994 .

[86]  M. K. Lee,et al.  Pharmacokinetics and organ distribution of cyclosporin A incorporated in liposomes and mixed micelles. , 1999, International journal of pharmaceutics.

[87]  Pişkin,et al.  Novel PDLLA/PEG copolymer micelles as drug carriers. , 1995, Journal of biomaterials science. Polymer edition.

[88]  J. Leroux,et al.  Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[89]  W. Pitt,et al.  Ultrasonic drug delivery – a general review , 2004, Expert opinion on drug delivery.

[90]  T. Park,et al.  In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[91]  You Han Bae,et al.  Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[92]  A. Kabanov,et al.  Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. , 1996, British Journal of Cancer.

[93]  J. Nah,et al.  Clonazepam release from poly(DL-lactide-co-glycolide) nanoparticles prepared by dialysis method , 1998, Archives of pharmacal research.

[94]  Teruo Okano,et al.  Analysis of Micelle Formation of an Adriamycin-Conjugated Poly(Ethylene Glycol)–Poly(Aspartic Acid) Block Copolymer by Gel Permeation Chromatography , 1993, Pharmaceutical Research.

[95]  J. Leroux,et al.  Micelles in anticancer drug delivery , 2004 .

[96]  T. Okano,et al.  Improved synthesis of adriamycin-conjugated poly (ethylene oxide)-poly (aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin , 1994 .

[97]  Teruo Okano,et al.  Block copolymer micelles for drug delivery: Loading and release of doxorubicin , 1997 .

[98]  Wim E Hennink,et al.  Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[99]  You Han Bae,et al.  Polymeric micelle for tumor pH and folate-mediated targeting. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[100]  Thermo-responsive self-assembled polymeric micelles for drug delivery in vitro. , 2000, International journal of pharmaceutics.

[101]  D. Maysinger,et al.  PCL-b-PEO micelles as a delivery vehicle for FK506: assessment of a functional recovery of crushed peripheral nerve. , 2000, Drug delivery.

[102]  H. Fain,et al.  Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[103]  N. Nishiyama,et al.  Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[104]  J. Leroux,et al.  Solubilization of cyclosporin A in dextran-g-polyethyleneglycolalkyl ether polymeric micelles. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[105]  G. Prestwich,et al.  Intracellular uptake and trafficking of Pluronic micelles in drug-sensitive and MDR cells: effect on the intracellular drug localization. , 2002, Journal of pharmaceutical sciences.

[106]  Alexander V. Kabanov,et al.  Effects of Pluronic Block Copolymers on Drug Absorption in Caco-2 Cell Monolayers , 1998, Pharmaceutical Research.

[107]  Yingli An,et al.  Biodegradable polylactide/poly(ethylene glycol)/polylactide triblock copolymer micelles as anticancer drug carriers , 2001 .

[108]  Donald W. Miller,et al.  Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. , 2001, The Journal of pharmacology and experimental therapeutics.

[109]  J. Curtis,et al.  Cyclosporine-induced nephrotoxicity: pathophysiology of decreased blood flow. , 1988, Transplantation proceedings.

[110]  A. Kabanov,et al.  Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. , 1997, Bioconjugate chemistry.

[111]  Chong-Su Cho,et al.  METHOXY POLY(ETHYLENE GLYCOL) AND CAPROLACTONE AMPHIPHILIC BLOCK CO POLYMERIC MICELLE CONTAINING INDOMETHACIN. II: MICELLE FORMATION AND DRUG RELEASE BEHAVIORS , 1998 .

[112]  A. Lavasanifar,et al.  Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[113]  Douglas A Christensen,et al.  Ultrasonic release of doxorubicin from Pluronic P105 micelles stabilized with an interpenetrating network of N,N-diethylacrylamide. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[114]  Y. M. Lee,et al.  Clonazepam release from core-shell type nanoparticles in vitro. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[115]  Teruo Okano,et al.  Physical Entrapment of Adriamycin in AB Block Copolymer Micelles , 1995, Pharmaceutical Research.

[116]  Teruo Okano,et al.  Soluble Self-Assembled Block Copolymers for Drug Delivery , 1999, Pharmaceutical Research.

[117]  K. Kataoka,et al.  NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel , 2005, British Journal of Cancer.

[118]  Kim Sung-chul,et al.  A polymeric micellar carrier for the solubilization of biphenyl dimethyl dicarboxylate , 2003, Archives of pharmacal research.

[119]  M. Jones,et al.  Polymeric micelles - a new generation of colloidal drug carriers. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[120]  F. Brunner,et al.  Acutely impaired renal function during intravenous administration of cyclosporine A: a cremophore side-effect. , 1986, Clinical nephrology.

[121]  Yuji Yamamoto,et al.  Surface charge modulation of poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles: Conjugation of charged peptides , 1999 .

[122]  G. Kwon,et al.  Preparation and Drug Loading of Poly(Ethylene Glycol)-block-Poly(ε-Caprolactone) Micelles Through the Evaporation of a Cosolvent Azeotrope , 2004, Pharmaceutical Research.

[123]  J. Leroux,et al.  Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[124]  J. Taillefer,et al.  Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs. , 2000, Journal of pharmaceutical sciences.

[125]  K. Kataoka,et al.  Smart Polyion Complex Micelles for Targeted Intracellular Delivery of PEGylated Antisense Oligonucleotides Containing Acid‐Labile Linkages , 2005, Chembiochem : a European journal of chemical biology.

[126]  K. Kataoka,et al.  Glutathione-sensitive stabilization of block copolymer micelles composed of antisense DNA and thiolated poly(ethylene glycol)-block-poly(L-lysine): a potential carrier for systemic delivery of antisense DNA. , 2001, Biomacromolecules.

[127]  M. Gleave,et al.  Polymeric micellar paclitaxel phosphorylates Bcl‐2 and induces apoptotic regression of androgen‐independent LNCaP prostate tumors , 2000, The Prostate.

[128]  N. Rapoport.  Stabilization and activation of Pluronic micelles for tumor-targeted drug delivery , 1999 .

[129]  A. Schaper,et al.  Core-cross-linked polymeric micelles as paclitaxel carriers. , 2004, Bioconjugate chemistry.

[130]  K. Kataoka,et al.  Stabilization of lysozyme-incorporated polyion complex micelles by the ω-end derivatization of poly(ethylene glycol)-poly(α,β-aspartic acid) block copolymers with hydrophobic groups , 2005 .

[131]  Glen S. Kwon,et al.  Methotrexate Esters of Poly(Ethylene Oxide)-Block-Poly(2-Hydroxyethyl-L-Aspartamide). Part I: Effects of the Level of Methotrexate Conjugation on the Stability of Micelles and on Drug Release , 2000, Pharmaceutical Research.

[132]  Marie-Hélène Dufresne,et al.  A Novel One-Step Drug-Loading Procedure for Water-Soluble Amphiphilic Nanocarriers , 2004, Pharmaceutical Research.

[133]  Afsaneh Lavasanifar,et al.  Amphiphilic block copolymers for drug delivery. , 2003, Journal of pharmaceutical sciences.

[134]  A. Kabanov,et al.  Fundamental Relationships Between the Composition of Pluronic Block Copolymers and Their Hypersensitization Effect in MDR Cancer Cells , 1999, Pharmaceutical Research.

[135]  W. Pitt,et al.  Ultrasonic activated drug delivery from Pluronic P-105 micelles. , 1997, Cancer letters.

[136]  Hua Ai,et al.  Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery , 2004 .

[137]  Yong Hu,et al.  Preparation, characterization, and drug release behaviors of drug nimodipine‐loaded poly(ε‐caprolactone)‐poly(ethylene oxide)‐poly(ε‐caprolactone) amphiphilic triblock copolymer micelles , 2002 .

[138]  M. Urioste,et al.  Concurrence of germline mutations in the APC and PTEN genes in a colonic polyposis family member. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[139]  I. Rubinstein,et al.  Interactions of human secretin with sterically stabilized phospholipid micelles amplify peptide-induced vasodilation in vivo , 2002, Peptides.

[140]  Daniel Dexter,et al.  An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel , 1997, Cancer Chemotherapy and Pharmacology.

[141]  Jean-Christophe Leroux,et al.  Stereocomplex block copolymer micelles: core-shell nanostructures with enhanced stability. , 2005, Nano letters.

[142]  M. Bally,et al.  LIPOSOMAL CYCLOSPORINE: COMPARISON OF DRUG AND LIPID CARRIER PHARMACOKINETICS AND BIODISTRIBUTION , 1995, Transplantation.

[143]  T. Okano,et al.  Preparation of micelle-forming polymer-drug conjugates. , 1992, Bioconjugate chemistry.

[144]  V. Torchilin,et al.  Diacyllipid-Polymer Micelles as Nanocarriers for Poorly Soluble Anticancer Drugs , 2002 .

[145]  Y. M. Lee,et al.  Methoxy poly(ethylene glycol) and epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviours. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[146]  W. Pitt,et al.  Drug delivery in polymeric micelles: from in vitro to in vivo. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[147]  T. Park,et al.  Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[148]  Kazunori Kataoka,et al.  Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. , 2005, Journal of the American Chemical Society.

[149]  Y. Nagasaki,et al.  Sugar-installed block copolymer micelles: their preparation and specific interaction with lectin molecules. , 2001, Biomacromolecules.

[150]  I. Kwon,et al.  Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone) copolymer as a carrier for paclitaxel , 2003 .

[151]  T. Okano,et al.  Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles. , 1996, Journal of pharmaceutical sciences.

[152]  J Verweij,et al.  Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. , 2001, European journal of cancer.

[153]  Tae Gwan Park,et al.  Folate receptor targeted biodegradable polymeric doxorubicin micelles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[154]  G. Kwon,et al.  Diblock copolymer nanoparticles for drug delivery. , 1998, Critical reviews in therapeutic drug carrier systems.

[155]  D. Maysinger,et al.  Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[156]  S. Fu,et al.  Stealth MePEG-PCL micelles: effects of polymer composition on micelle physicochemical characteristics, in vitro drug release, in vivo pharmacokinetics in rats and biodistribution in S180 tumor bearing mice , 2005 .

[157]  W. Pitt,et al.  DNA damage induced by micellar-delivered doxorubicin and ultrasound: comet assay study. , 2000, Cancer letters.

[158]  S. V. Vinogradov,et al.  Water-soluble block polycations as carriers for oligonucleotide delivery. , 1995, Bioconjugate chemistry.

[159]  A. Kabanov,et al.  Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials , 1999 .

[160]  T. Okano,et al.  Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. , 1990, Cancer research.

[161]  D. Kerr,et al.  Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer , 2004, British Journal of Cancer.

[162]  Alexander V. Kabanov,et al.  Inhibition of Multidrug Resistance-Associated Protein (MRP) Functional Activity with Pluronic Block Copolymers , 1999, Pharmaceutical Research.

[163]  Vladimir P. Torchilin,et al.  Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[164]  Y. Sugiyama,et al.  Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. , 2003, Cancer research.

[165]  G. Kwon,et al.  Micelles of poly(ethylene oxide)-block-poly(N-alkyl stearate L-aspartamide): synthetic analogues of lipoproteins for drug delivery. , 2000, Journal of biomedical materials research.

[166]  Alexander V. Kabanov,et al.  Pluronic P85 Increases Permeability of a Broad Spectrum of Drugs in Polarized BBMEC and Caco-2 Cell Monolayers , 1999, Pharmaceutical Research.

[167]  M. Ranson,et al.  A phase II, window study of SP1049C as first-line therapy in inoperable metastatic adenocarcinoma of the oesophagus. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[168]  H. Uludaǧ,et al.  Effect of molecular weight of thermoreversible polymer on in vivo retention of rhBMP-2. , 2001, Journal of biomedical materials research.

[169]  Yong Hu,et al.  Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) amphiphilic triblock copolymer micelles. , 2002, Journal of pharmaceutical sciences.

[170]  Y. M. Lee,et al.  Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[171]  T. Okano,et al.  Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[172]  T. Okano,et al.  Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[173]  K. Kataoka,et al.  A core-shell-type fluorescent nanosphere possessing reactive poly(ethylene glycol) tethered chains on the surface for zeptomole detection of protein in time-resolved fluorometric immunoassay. , 2003, Analytical chemistry.

[174]  Jinming Gao,et al.  Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[175]  V. Torchilin,et al.  Targeted polymeric micelles for delivery of poorly soluble drugs , 2004, Cellular and Molecular Life Sciences CMLS.

[176]  T. Okano,et al.  Development of the polymer micelle carrier system for doxorubicin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[177]  K. Kataoka,et al.  pH-responsive oligodeoxynucleotide (ODN)-poly(ethylene glycol) conjugate through acid-labile beta-thiopropionate linkage: preparation and polyion complex micelle formation. , 2003, Biomacromolecules.

[178]  C. Freise,et al.  Liposomal Cyclosporine A , 1996 .

[179]  Christine Allen,et al.  Nano-engineering block copolymer aggregates for drug delivery , 1999 .

[180]  F. Moriyasu,et al.  Pharmaceutical and Biomedical Differences between Micellar Doxorubicin (NK911) and Liposomal Doxorubicin (Doxil) , 2002, Japanese journal of cancer research : Gann.

[181]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[182]  H. Ueno,et al.  Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin , 2004, British Journal of Cancer.

[183]  R. Weissleder,et al.  An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: synthesis and cytotoxic properties. , 1996, Bioconjugate chemistry.

[184]  J. Leroux,et al.  pH-sensitive unimolecular polymeric micelles: synthesis of a novel drug carrier. , 2003, Bioconjugate chemistry.

[185]  G. Kwon,et al.  Polymeric micelles for delivery of poorly water-soluble compounds. , 2003, Critical reviews in therapeutic drug carrier systems.